Bryan Lawlis V.

President, ARADIGM CORP.

Companies

Geron CorporationBoard member Mar 15, 2012 to now¹
BioMarin PharmaceuticalBoard member Jun 21, 2007 to May 24, 2023²
Aeglea BioTherapeuticsBoard member Jul 17, 2018 to Jun 9, 2022³
Coherus BioSciences (United States)Board member Nov 6, 2014 to Jan 13, 2021⁴
Sutro BiopharmaBoard member Sep 26, 2018 to Sep 27, 2018⁵
HUMANIGEN, INCBoard member Aug 15, 2013 to Jun 20, 2014⁶

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

May 9, 2025Bought 13,300 shares at $1.18 of Geron Corporation⁸
May 15, 2024Sold 35,000 shares at $3.75 of Geron Corporation⁹
May 15, 2024Exercised options 35,000 shares at $1.94 of Geron Corporation⁹
May 23, 2023Granted 4,190 shares of BioMarin Pharmaceutical⁷
May 11, 2023Sold 35,000 shares at $3.00 of Geron Corporation¹⁰
May 11, 2023Exercised options 35,000 shares at $1.10 of Geron Corporation¹⁰
Apr 3, 2023Sold 8,500 shares at $97.09 of BioMarin Pharmaceutical¹¹
Apr 3, 2023Exercised options 8,500 shares at $67.81 of BioMarin Pharmaceutical¹¹
May 24, 2022Granted 4,980 shares of BioMarin Pharmaceutical¹²
Apr 14, 2022Sold 4,250 shares at $83.66 of BioMarin Pharmaceutical¹³
Apr 14, 2022Exercised options 4,250 shares at $37.46 of BioMarin Pharmaceutical¹³
Jan 14, 2022Sold 4,250 shares at $87.61 of BioMarin Pharmaceutical¹⁴
Jan 14, 2022Exercised options 4,250 shares at $37.46 of BioMarin Pharmaceutical¹⁴

The numbers on this page point here. Each one links to the record it came from.